Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies

Background: Cystatin C (CysC) is a renal function marker that is not as influenced as creatinine (Cr) by endogenous or exogenous agents, so it is proposed as a marker in preterm infants. Objectives: To determine serum CysC values in preterm infants during the first week of life, compared to Cr. To a...

Full description

Bibliographic Details
Main Authors: Leonor Bardallo Cruzado, Elena Pérez González, Zoraima Martínez Martos, Carmen Bermudo Guitarte, Mercedes Granero Asencio, Salud Luna Lagares, Mariano Marín Patón, Juan Polo Padilla
Format: Article
Language:English
Published: Elsevier 2015-05-01
Series:Nefrología (English Edition)
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S201325141500022X
id doaj-12641cfdb4354a91983fb229d40df1b0
record_format Article
spelling doaj-12641cfdb4354a91983fb229d40df1b02020-11-25T00:47:51ZengElsevierNefrología (English Edition)2013-25142015-05-0135329630310.1016/j.nefroe.2015.06.003Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologiesLeonor Bardallo Cruzado0Elena Pérez González1Zoraima Martínez Martos2Carmen Bermudo Guitarte3Mercedes Granero Asencio4Salud Luna Lagares5Mariano Marín Patón6Juan Polo Padilla7UGC Neonatología, Hospital Universitario Virgen Macarena, Sevilla, SpainUnidad de Nefrología Pediátrica, UGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC Bioquímica Clínica, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC Neonatología, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC Neonatología, Hospital Universitario Virgen Macarena, Sevilla, SpainUnidad de Nefrología Pediátrica, UGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, SpainDepartamento de Bioestadística, Universidad de Sevilla, Sevilla, SpainBackground: Cystatin C (CysC) is a renal function marker that is not as influenced as creatinine (Cr) by endogenous or exogenous agents, so it is proposed as a marker in preterm infants. Objectives: To determine serum CysC values in preterm infants during the first week of life, compared to Cr. To analyse alterations caused by prematurity diseases. Method: The design involved a longitudinal, observational study of prospective cohorts. Groups were based on gestational age (GA): Group A (24–27 weeks), Group B (28–33 weeks), Group C (34–36 weeks). Blood samples were collected at birth, within 48–72 h and after 7 days of life. Statistics: SPSS v.20 software was used. The statistical methods applied included chi-squared test and ANOVA. Results: A total of 109 preterm infants were included in the study. CysC levels were 1.54 mg/l (±0.28) at birth, 1.38 mg/l (±0.36) within 48–72 h of life, and 1.50 mg/l (± 0.31) after 7 days (p < 0.05). Cr levels were 0.64 mg/dl (±0.17) at birth, 0.64 mg/dl (± 0.28) within 48–72 h, and 0.56 mg/dl (± 0.19) after 7 days (P < .05). CysC values were lower in hypotensive patients and in those with a respiratory disease (P < .05), and no alterations associated with other diseases were observed. There were no differences in Cr levels associated with any disease. Creatinine levels were higher in patients ≤1.500 g (P < .05). Conclusions: Serum CysC decreased within 48–72 h of life, and this decline showed significance (P < .05). The levels increased after 7 days in all 3 GA groups, and there was no difference in CysC levels among the groups. More studies in preterm infants with hypotension and respiratory disease are required. CysC is a better glomerular filtration rate (GFR) marker in ≤1.500 g preterm infants.http://www.sciencedirect.com/science/article/pii/S201325141500022XCystatin CCreatininePremature infant
collection DOAJ
language English
format Article
sources DOAJ
author Leonor Bardallo Cruzado
Elena Pérez González
Zoraima Martínez Martos
Carmen Bermudo Guitarte
Mercedes Granero Asencio
Salud Luna Lagares
Mariano Marín Patón
Juan Polo Padilla
spellingShingle Leonor Bardallo Cruzado
Elena Pérez González
Zoraima Martínez Martos
Carmen Bermudo Guitarte
Mercedes Granero Asencio
Salud Luna Lagares
Mariano Marín Patón
Juan Polo Padilla
Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
Nefrología (English Edition)
Cystatin C
Creatinine
Premature infant
author_facet Leonor Bardallo Cruzado
Elena Pérez González
Zoraima Martínez Martos
Carmen Bermudo Guitarte
Mercedes Granero Asencio
Salud Luna Lagares
Mariano Marín Patón
Juan Polo Padilla
author_sort Leonor Bardallo Cruzado
title Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
title_short Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
title_full Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
title_fullStr Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
title_full_unstemmed Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
title_sort serum cystatin c levels in preterm newborns in our setting: correlation with serum creatinine and preterm pathologies
publisher Elsevier
series Nefrología (English Edition)
issn 2013-2514
publishDate 2015-05-01
description Background: Cystatin C (CysC) is a renal function marker that is not as influenced as creatinine (Cr) by endogenous or exogenous agents, so it is proposed as a marker in preterm infants. Objectives: To determine serum CysC values in preterm infants during the first week of life, compared to Cr. To analyse alterations caused by prematurity diseases. Method: The design involved a longitudinal, observational study of prospective cohorts. Groups were based on gestational age (GA): Group A (24–27 weeks), Group B (28–33 weeks), Group C (34–36 weeks). Blood samples were collected at birth, within 48–72 h and after 7 days of life. Statistics: SPSS v.20 software was used. The statistical methods applied included chi-squared test and ANOVA. Results: A total of 109 preterm infants were included in the study. CysC levels were 1.54 mg/l (±0.28) at birth, 1.38 mg/l (±0.36) within 48–72 h of life, and 1.50 mg/l (± 0.31) after 7 days (p < 0.05). Cr levels were 0.64 mg/dl (±0.17) at birth, 0.64 mg/dl (± 0.28) within 48–72 h, and 0.56 mg/dl (± 0.19) after 7 days (P < .05). CysC values were lower in hypotensive patients and in those with a respiratory disease (P < .05), and no alterations associated with other diseases were observed. There were no differences in Cr levels associated with any disease. Creatinine levels were higher in patients ≤1.500 g (P < .05). Conclusions: Serum CysC decreased within 48–72 h of life, and this decline showed significance (P < .05). The levels increased after 7 days in all 3 GA groups, and there was no difference in CysC levels among the groups. More studies in preterm infants with hypotension and respiratory disease are required. CysC is a better glomerular filtration rate (GFR) marker in ≤1.500 g preterm infants.
topic Cystatin C
Creatinine
Premature infant
url http://www.sciencedirect.com/science/article/pii/S201325141500022X
work_keys_str_mv AT leonorbardallocruzado serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
AT elenaperezgonzalez serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
AT zoraimamartinezmartos serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
AT carmenbermudoguitarte serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
AT mercedesgraneroasencio serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
AT saludlunalagares serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
AT marianomarinpaton serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
AT juanpolopadilla serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies
_version_ 1725258168337956864